Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency

Clinica Chimica Acta

Volumn 301, Issue 1-2, 2000, Pages 103-117

  Arai, Tomoko ^a,b   Tsukada, Toshihiko ^a   Murase, Toshio ^a   Matsumoto, Kojiro ^b  

^a TORANOMON HOSPITAL   (Japan)

^b Sch Pharmaceutical Sci Toho U   (Japan)

Author keywords

Cholesteryl ester transfer protein (CETP); High density lipoproteins (HDL); Particle size

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; POLYACRYLAMIDE GEL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; ELECTROPHORESIS; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TISSUE DISTRIBUTION;

ADULT; AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; LIPOPROTEINS, HDL; MALE; MIDDLE AGE; PARTICLE SIZE;

EID: 0033800003     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00328-4     Document Type: Article

References (28)

1. Bruce C., Chouinard R.A. Jr., Tall A.R. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr. 18:1998;297-330.
2. Hill S.A., McQueen M.J. Reverse cholesterol transport: A review of the process and its clinical implications. Clin Biochem. 30:1997;517-525.
3. Inazu A., Koizumi J., Haraki T., et al. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia. Hum Genet. 91:1993;13-16.
4. Hirano K., Yamashita S., Funahashi T., et al. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population: Relation between the mutation and hyperalphalipoproteinemia. Atherosclerosis. 100:1993;85-90.
5. Sakai N., Yamashita S., Hirano K., et al. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects. Atherosclerosis. 114:1995;139-145.
6. Inazu A., Jiang X.C., Haraki T., et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest. 94:1994;1872-1882.
7. Castelli W.P. Epidemiology of coronary heart disease: The Framingham study. Am J Med. 76:(2A):1984;4-12.
8. Gordon D.J., Rifkind B.M. High density lipoprotein: The clinical implications of recent studies. N Engl J Med. 321:1989;1311-1316.
9. Walsh A., Ito Y., Breslow J.L. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL2. J Biol Chem. 264:1989;6488-6494.
10. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.G., Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353:1991;265-267.
11. Yamashita S., Matsuzawa Y., Okazaki M., et al. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity. Atherosclerosis. 70:1988;7-12.
12. Ishigami M., Yamashita S., Sakai N., et al. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J Biochem (Tokyo). 116:1994;257-262.
13. Arai T., Tsukada T., Nakayama T. Simple and rapid detection of cholesteryl ester transfer protein deficiency by using nonradioisotopic single-strand conformation polymorphism analysis. Clin Chem. 40:1994;2227-2229.
14. Li Z., McNamara J.R., Ordovas J.M., Schaefer E.J. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J Lipid Res. 35:1994;1698-1711.
15. Blanche P.J., Gong E.L., Forte T.M., Nichols A.V. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta. 665:1981;408-419.
16. Wieland H., Seidel D. Improved assessment of plasma lipoprotein patterns: IV. Simple preparation of a lyophilized control serum containing intact human plasma lipoproteins. Clin Chem. 28:1982;1335-1337.
17. Friedewald W.L., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
18. Kiyohara T., Kiriyama R., Zamma S., et al. Enzyme immunoassay for cholesteryl ester transfer protein in human serum. Clin Chim Acta. 271:1998;109-118.
19. Hayek T., Azrolan N., Verdery R.B., Walsh A., Chajek-Shaul T. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein concentrations, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest. 92:1993;1143-1152.
20. Lagrost L., Athias A., Herbeth B., et al. Opposite effects of cholesteryl ester transfer protein and phospholipid transfer protein on the size distribution of plasma high density lipoproteins. Physiological relevance in alcoholic patients. J Biol Chem. 271:1996;19058-19065.
21. Bisgaier C.L., Siebenkas M.V., Brown M.L., et al. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin. J Lipid Res. 32:1991;21-33.
22. Gotoda T., Kinoshita M., Shimano H., et al. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA. Biochem Biophys Res Commun. 194:1993;519-524.
23. Sakai N., Santamarina-Fojo S., Yamashita S., Matsuzawa Y., Brewer H.B. Jr. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. J Lipid Res. 37:1996;2065-2073.
24. Arai T., Yamashita S., Sakai N., et al. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. J Lipid Res. 37:1996;2145-2154.
25. Chiba H., Akita H., Tsuchihashi K., et al. Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency. J Lipid Res. 38:1997;1204-1216.
26. Inazu A., Brown M.L., Hesler C.B., et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 323:1990;1234-1238.
27. Hirano K., Yamashita S., Nakajima N., et al. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipo-proteinemia caused by CETP gene mutation is not associated with longevity. Arterioscler Thromb Vasc Biol. 17:1997;1053-1059.
28. Zhong S., Sharp D.S., Grove J.S., et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest. 97:1996;2917-2923.